Sanofi India is currently trading at Rs. 2328.95, up by 29.05 points or 1.26% from its previous closing of Rs. 2299.90 on the BSE.
The scrip opened at Rs. 2299.00 and has touched a high and low of Rs. 2330.00 and Rs. 2279.00 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2429.95 on 02-Jan-2012 and a 52 week low of Rs. 2002.10 on 07-Jun-2012.
Last one week high and low of the scrip stood at Rs. 2326.00 and Rs. 2078.60 respectively. The current market cap of the company is Rs. 5252.02 crore.
The promoters holding in the company stood at 60.40% while Institutions and Non-Institutions held 27.73% and 11.88% respectively.
Sanofi India's unit Merial has inked pact with India-based drugmaker Dosch Pharmaceuticals by signing an agreement to buy the animal health business. Through this initiative, it aims to increase its presence in growing market. The deal is expected to be finalised in the first half of 2013.
The company has registered a fall of 18.51% in its net profit at Rs 40.50 crore for second quarter ended June 30, 2012 as compared to Rs 49.70 crore for the same quarter in the previous year. However, the total income from operation of the company has increased by 21.87% at Rs 392.80 crore for second quarter as compared Rs 322.30 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |